Bimekizumab 3-year Efficacy in High-Impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from Five Phase 3/3b Trials. (2024). SKIN The Journal of Cutaneous Medicine, 8(1), s304. https://doi.org/10.25251/skin.8.supp.304